UK markets close in 6 hours 50 minutes

Esperion Therapeutics Inc (0ET.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
1.9730-0.0570 (-2.82%)
As of 10:10AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
229,740
116,334
75,475
78,447
227,547
-
Cost of revenue
41,690
43,267
26,967
14,217
2,392
-
Gross profit
188,050
73,067
48,508
64,230
225,155
-
Operating expenses
Research development
68,129
86,107
118,927
105,975
146,936
-
Selling general and administrative
154,610
142,523
109,082
184,985
199,615
-
Total operating expenses
222,739
228,630
228,009
290,960
346,551
-
Operating income or loss
-34,689
-155,563
-179,501
-226,730
-121,396
-
Interest expense
58,613
58,976
56,810
46,353
22,670
-
Total other income/expenses net
6,795
5,291
2,652
3,975
515
-
Income before tax
-86,507
-209,248
-233,659
-269,108
-143,551
-
Income from continuing operations
-86,507
-209,248
-233,659
-269,108
-143,551
-
Net income
-86,507
-209,248
-233,659
-269,108
-143,551
-
Net income available to common shareholders
-86,507
-209,248
-233,659
-269,108
-143,551
-
Basic EPS
-3.52
-
-3.52
-9.31
-5.23
-3.59
Diluted EPS
-3.52
-
-3.52
-9.31
-5.23
-3.59
Basic average shares
66,407
-
66,407
28,903
27,474
27,090
Diluted average shares
66,407
-
66,407
28,903
27,474
27,090